Search Results - "Gaugris, Sabine"

Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30 by Rowen, Donna, PhD, MSc, Brazier, John, PhD, MSc, Young, Tracey, PhD, CStat, MSc, Gaugris, Sabine, MSc, Craig, Benjamin M., PhD, MS, King, Madeleine T., PhD, Velikova, Galina, MD, PhD

“…Abstract Objective The European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) is one of the most…”
Get full text

Comparison of Generic, Condition-Specific, and Mapped Health State Utility Values for Multiple Myeloma Cancer by Rowen, Donna, PhD, MSc, BA, Young, Tracey, PhD, CStat, MSc, BSc, Brazier, John, PhD MSc BA, Gaugris, Sabine, MSc

“…Abstract Objective Resource allocation informed by cost-utility analysis requires that the benefits be comparable across patient groups and interventions. One…”
Get full text

A Budget-Impact (BI) Analysis of Tazemetostat for the Treatment of 3L+ Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States by Watson, Lucy, Harrison, Owen, Cockrum, Paul, Veazey, Kylee, Gaugris, Sabine, Kim, George

Get full text

IBCL-461 A Budget-Impact (BI) Analysis of Tazemetostat for the Treatment of 3L+ Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States by Watson, Lucy, Harrison, Owen, Cockrum, Paul, Veazey, Kylee, Gaugris, Sabine, Kim, George

“…FL is the second most common subtype of non-Hodgkin lymphoma in the United States, with an annual incidence of 15,000 patients. In 20% to 25% of FL patients…”
Get full text

Hospitalizations for Upper and Lower GI Events Associated With Traditional NSAIDs and Acetaminophen Among the Elderly in Quebec, Canada by RAHME, Elham, BARKUN, Alan, NEDJAR, Hacene, GAUGRIS, Sabine, WATSON, Douglas

“…The risk of upper/lower gastrointestinal (GI) adverse events associated with the concomitant use of traditional nonsteroidal anti-inflammatory drugs (tNSAIDs)…”
Get full text

The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis by Jackson, C., Gaugris, S., Sen, S.S., Hosking, D.

“…We evaluated the effect of supplementation with vitamin D3 (excluding the potential effect of calcium supplementation) on the risk of fall and fracture,…”
Get full text

Burden of Concomitant Allergic Rhinitis in Adults with Asthma by Gaugris, Sabine, Sazonov-Kocevar, Vasilisa, Thomas, Mike

“…Asthma (A) and allergic rhinitis (AR) are common conditions with evidence of shared epidemiological and patho-physiological backgrounds. A systematic review of…”
Get full text

Indirect Comparison of the Efficacy of Melphalan-Prednisone-Bortezomib Relative to Melphalan-Prednisone-Thalidomide and Melphalan-Prednisone for the First Line Treatment of Multiple Myeloma by Yeh, Yating, Chambers, James, Gaugris, Sabine, Jansen, Jeroen

“…Melphalan-prednisone (MP) combination has been considered a standard of care for front line treatment of multiple myeloma in patients non eligible for…”
Get full text

Outcomes in Relapsed Multiple Myeloma in the UK: A Retrospective Observational Study by Yong, Kwee, Percival, Fran, Auger, Martin, Basu, Supratik, Chu, Patrick, Aldouri, Maadh, Gaugris, Sabine

“…Recent availability of active drugs (proteasome inhibitor (PI) and IMiDs) for the treatment of multiple myeloma (MM) has changed the outlook for patients who…”
Get full text

Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands by Jansen, Jeroen P., Gaugris, Sabine, Bergman, Gert, Sen, Shuvayu S.

“…ABSTRACT Objective: To evaluate the cost-effectiveness of a fixed dose combination of alendronate 70 mg and cholecalciferol 2800 IU (alendronate/vitamin D3;…”
Get full text

Relapsed multiple myeloma in the UK prior to the introduction of novel agents - a response to by QUINN, JOHN, PERCIVAL, FRAN, AUGER, MARTIN, BASU, SUPRATIK, CHU, PATRICK, ALDOURI, MAADH, LAMBOURNE, ADRIAN, GAUGRIS, SABINE, YONG, KWEE

Get full text

Relapsed multiple myeloma in the UK prior to the introduction of novel agents - a response to Koleva. (2010) by Quinn, JOHN, Percival, FRAN, Auger, MARTIN, Basu, SUPRATIK, Chu, PATRICK, Aldouri, MAADH, Lambourne, ADRIAN, Gaugris, SABINE, Yong, KWEE

Get full text

Relapsed multiple myeloma in the UK prior to the introduction of novel agents – a response to Koleva et al. (2010) by QUINN, JOHN, PERCIVAL, FRAN, AUGER, MARTIN, BASU, SUPRATIK, CHU, PATRICK, ALDOURI, MAADH, LAMBOURNE, ADRIAN, GAUGRIS, SABINE, YONG, KWEE

Get full text

Relapsed multiple myeloma in the UK prior to the introduction of novel agents - a response to Koleva et al. (2010): Letter to the editor by QUINN, JOHN, PERCIVAL, FRAN, AUGER, MARTIN, BASU, SUPRATIK, CHU, PATRICK, ALDOURI, MAADH, LAMBOURNE, ADRIAN, GAUGRIS, SABINE, YONG, KWEE

Get full text

Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands by Van der Linden, Michiel W., Gaugris, Sabine, Kuipers, Ernst J., Van den Bemt, Bart J. F., van Herk-Sukel, Myrthe P. P., Herings, Ron M. C.

“…ABSTRACT Objective: To describe the use of gastroprotection (GP) among new chronic users of NSAIDs in the Netherlands by gastrointestinal (GI) risk factor (RF)…”
Get full text

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis by Jansen, Jeroen P., Gaugris, Sabine, Choy, Ernest H., Ostor, Andrew, Nash, Julian T., Stam, Wiro

“…Objective : To evaluate the cost effectiveness of etoricoxib (90mg/day) relative to celecoxib (200 or 400mg/day), and the non-selective NSAIDs naproxen…”
Get full text

W1060 Hospitalizations for Gastrointestinal Events Among Users of COX-2 Inhibitors Compared with Traditional Non-Steroidal Anti-Inflammatory Drugs with Proton-Pump Inhibitors by van der Linden, Michiel W, Kuipers, E.J, Sukel, Myrthe P, Herings, Ron M, Gaugris, Sabine

Get full text

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors by van der Linden, Michiel W., Gaugris, Sabine, Kuipers, Ernst J., van Herk-Sukel, Myrthe P. P., van den Bemt, Bart J. F., Sen, Shuvayu S., Herings, Ron M. C.

“…Purpose To compare hospitalization rates for serious upper and lower gastrointestinal (GI) events between chronic and acute users of a traditional…”
Get full text